# Whole Brain Radiotherapy With or Without Temozolomide at Daily Fixed-dose for Brain Metastases Treatment

> **NCT01015534** · PHASE2 · COMPLETED · sponsor: **Instituto Nacional de Cancerologia de Mexico** · enrollment: 55 (actual)

## Conditions studied

- Brain Neoplasms

## Interventions

- **DRUG:** Temozolomide
- **RADIATION:** Whole brain irradiation

## Key facts

- **NCT ID:** NCT01015534
- **Lead sponsor:** Instituto Nacional de Cancerologia de Mexico
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2009-10
- **Final completion:** 2009-10
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2013-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01015534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01015534, "Whole Brain Radiotherapy With or Without Temozolomide at Daily Fixed-dose for Brain Metastases Treatment". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01015534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*